Condição autossômica dominante causada por mutação(ões) no gene CAV3, que codifica a caveolina-3. É caracterizada por contrações dos músculos esqueléticos desencadeadas mecanicamente. A distrofia muscular de cinturas tipo 1C é um distúrbio alélico com um fenótipo sobreposto.
Introdução
O que você precisa saber de cara
A doença de músculo rippling é uma condição genética rara que afeta os músculos esqueléticos, fazendo com que eles tenham contrações visíveis em ondas após serem tocados ou pressionados. Além dessas ondas musculares, quem tem essa condição costuma sentir dor, câimbras e rigidez após fazer exercícios, acompanhadas de fraqueza nos braços ou nas coxas e aumento da panturrilha. A causa está ligada a mutações no gene CAV3, que podem ser herdadas tanto de forma dominante quanto recessiva. No Brasil, a doença não conta com um protocolo PCDT próprio nem remédios específicos fornecidos pelo SUS, mas o sistema público oferece procedimentos como reabilitação e exames genéticos.
Condição autossômica dominante causada por mutação(ões) no gene CAV3, que codifica a caveolina-3. É caracterizada por contrações dos músculos esqueléticos desencadeadas mecanicamente. A distrofia muscular de cinturas tipo 1C é um distúrbio alélico com um fenótipo sobreposto.
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 14 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.
HyperCKmia
Characterized by persistent elevated levels of serum creatine kinase without muscle weakness.
Variantes genéticas (ClinVar)
145 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
1 via biológica associada aos genes desta condição.
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Doença de músculo rippling
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Pesquisa e ensaios clínicos
Nenhum ensaio clínico registrado para esta condição.
Publicações mais relevantes
High-Throughput Immunoassays for Cavin-4 IgG: A Diagnostic Tool for Immune-Mediated Rippling Muscle Disease.
Cavin-4 was identified as a potential autoantigen for immune-mediated rippling muscle disease (iRMD). To validate this, we developed and tested various immunoassays, including a cell-based assay (CBA), cavin-4 recombinant protein ELISA, and multi-peptide ELISA. Among 19 iRMD patients, all exhibited muscle rippling, and 13 had percussion-induced mounding. All immunoassays demonstrated clinical and analytical specificities greater than 95%. The protein ELISA had the highest sensitivity (94.7%) and specificity (99.9%), outperforming CBA (sensitivity 89.5%, specificity 99.6%) and the multi-peptide ELISA (sensitivity 79.0%, specificity 97.2%). Our results suggest that the cavin-4 protein ELISA is a promising tool for high-throughput clinical testing in iRMD.
Clinical Phenotype Spectrum in Two Large Chinese Families With Rippling Muscle Disease Caused by CAV-3 c.80G>A.
Rippling muscle disease (RMD) is a rare benign myotonic myopathy caused by pathogenic variants in the caveolin-3 (CAV-3) gene and is characterized by highly irritable muscles, transient localized muscle bulges, and ripple-like contractions. There is still a lack of systematic understanding of the phenotypic spectrum of RMD. In this study, clinical data were collected from patients with RMD. The analysis of the pathogenic variants in the CAV-3 gene was conducted by next-generation sequencing and Sanger sequencing. Changes in the expression of the CAV3 protein were analyzed by immunohistochemistry and western blotting. In addition, we performed a literature review of previously reported RMD patients. A total of 12 patients with RMD were clinically diagnosed in two families. All patients presented with childhood-onset exercise intolerance, muscle stiffness, and myalgia after exercise. Percussion-induced rapid muscle mounding and contractions were observed in all patients. Electromyography revealed myogenic damage in Patient 1 and Patient 2. Muscle MRI of the thigh and leg suggested mild muscle atrophy in Patient 2. Muscle pathology revealed nonspecific myopathy-like changes in Patient 2. A heterozygous variant c.80G>A (p.Arg27Gln) in the CAV3 gene was identified in all patients with RMD. Immunohistochemical and western blot analyses revealed reduced expression of the CAV3 protein in muscle tissue. These results demonstrated the clinical, electromyographical, and pathological features of RMD patients in two large Chinese families, with reviewing the literature, provide a better understanding of the variable RMD phenotypes. Trial Registration: SJNKHDJ20221213160659.
Unraveling calcium dysregulation and autoimmunity in immune mediated rippling muscle disease.
Rippling Muscle Disease (RMD) is a rare skeletal myopathy characterized by abnormal muscular excitability manifesting with wave-like muscle contractions and percussion-induced muscle mounding. Hereditary RMD is associated with caveolin-3 or cavin-1 mutations. Recently, we identified cavin 4 autoantibodies as a biomarker of immune-mediated RMD (iRMD), though the underlying disease-mechanisms remain poorly understood. Transcriptomic studies were performed on muscle biopsies of 8 patients (5 males; 3 females; ages 26-to-80) with iRMD. Subsequent pathway analysis compared iRMD to human non-disease control and disease control (dermatomyositis) muscle samples. Transcriptomic studies demonstrated changes in key pathways of muscle contraction and development. All iRMD samples had significantly upregulated cavin-4 expression compared to controls, likely compensatory for autoantibody-mediated protein degradation. Proteins involved in muscle relaxation (including SERCA1, PMCA and PLN) were significantly increased in iRMD compared to controls. Comparison of iRMD to dermatomyositis transcriptomics demonstrated significant overlap in immune pathways, and the IL-6 signaling pathway was markedly increased in all iRMD patient muscle biopsies and increased in the majority of iRMD patients' serum. This study represents the first muscle transcriptomic analysis of iRMD patients and dissects underlying disease mechanisms. Increase of sarcolemmal and cellular calcium channels as well as PLN, an inhibitor of the SERCA pump for calcium into the sarcoplasm, likely alters the calcium dynamics in iRMD. These changes in crucial components of muscle relaxation may underlie rippling by altering calcium flux. Our findings provide crucial insights into the differential expression of genes regulating muscle relaxation and highlight potential disease pathomechanisms.
The spectrum of rippling muscle disease.
Rippling muscle disease (RMD) is a rare disorder of muscle hyperexcitability. It is characterized by rippling wave-like muscle contractions induced by mechanical stretch or voluntary contraction followed by sudden stretch, painful muscle stiffness, percussion-induced rapid muscle contraction (PIRC), and percussion-induced muscle mounding (PIMM). RMD can be hereditary (hRMD) or immune-mediated (iRMD). hRMD is caused by pathogenic variants in caveolin-3 (CAV3) or caveolae-associated protein 1/ polymerase I and transcript release factor (CAVIN1/PTRF). CAV3 pathogenic variants are autosomal dominant or less frequently recessive while CAVIN1/PTRF pathogenic variants are autosomal recessive. CAV3-RMD manifests with a wide spectrum of clinical phenotypes, ranging from asymptomatic creatine kinase elevation to severe muscle weakness. Overlapping phenotypes are common. Muscle caveolin-3 immunoreactivity is often absent or diffusely reduced in CAV3-RMD. CAVIN1/PTRF-RMD is characterized by congenital generalized lipodystrophy (CGL, type 4) and often accompanied by several extra-skeletal muscle manifestations. Muscle cavin-1/PTRF immunoreactivity is absent or reduced while caveolin-3 immunoreactivity is reduced, often in a patchy way, in CAVIN1/PTRF-RMD. iRMD is often accompanied by other autoimmune disorders, including myasthenia gravis. Anti-cavin-4 antibodies are the serological marker while the mosaic expression of caveolin-3 and cavin-4 is the pathological feature of iRMD. Most patients with iRMD respond to immunotherapy. Rippling, PIRC, and PIMM are usually electrically silent. Different pathogenic mechanisms have been postulated to explain the disease mechanisms. In this article, we review the spectrum of hRMD and iRMD, including clinical phenotypes, electrophysiological characteristics, myopathological findings, and pathogenesis.
Correction: Unraveling calcium dysregulation and autoimmunity in immune mediated rippling muscle disease.
Publicações recentes
Clinical Phenotype Spectrum in Two Large Chinese Families With Rippling Muscle Disease Caused by CAV-3 c.80G>A.
High-Throughput Immunoassays for Cavin-4 IgG: A Diagnostic Tool for Immune-Mediated Rippling Muscle Disease.
Unraveling calcium dysregulation and autoimmunity in immune mediated rippling muscle disease.
The spectrum of rippling muscle disease.
📚 EuropePMC65 artigos no totalmostrando 61
Clinical Phenotype Spectrum in Two Large Chinese Families With Rippling Muscle Disease Caused by CAV-3 c.80G>A.
Neuropathology : official journal of the Japanese Society of NeuropathologyHigh-Throughput Immunoassays for Cavin-4 IgG: A Diagnostic Tool for Immune-Mediated Rippling Muscle Disease.
Annals of clinical and translational neurologyUnraveling calcium dysregulation and autoimmunity in immune mediated rippling muscle disease.
Acta neuropathologica communicationsThe spectrum of rippling muscle disease.
Muscle & nerveHeat therapy in rheumatic and musculoskeletal diseases - an overview of clinical and molecular effects.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia GroupDrug persistence in patients with rheumatic and musculoskeletal diseases during a major economic crisis: results from a nationwide cross-sectional online survey.
Rheumatology internationalStakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group.
Seminars in arthritis and rheumatismMultimorbidity in rheumatoid arthritis: common mechanistic links and impact and challenges in routine clinical practice.
Rheumatology (Oxford, England)Generation of two human iPSC lines (HIMRi002-A and HIMRi003-A) derived from Caveolinopathy patients with rippling muscle disease.
Stem cell researchImpact of COVID-19 on disease (self) management and well-being in people with Rheumatic or Musculoskeletal diseases across four European countries: a mixed methods study.
ARP rheumatologyRe-thinking the perception of long-term opioid use in RMDs.
Nature reviews. RheumatologyTrends in consultations and prescribing for rheumatic and musculoskeletal diseases: an electronic primary care records study.
The British journal of general practice : the journal of the Royal College of General PractitionersDeveloping a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needs.
RMD openProtocol for a systematic literature review of smartphone apps to support the self-management of rheumatic and musculoskeletal diseases: development strategies, theoretical underpinnings and barriers to engagement.
Systematic reviewsTrends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021.
Rheumatology (Oxford, England)Living with foot and ankle disorders in rheumatic and musculoskeletal diseases: A systematic review of qualitative studies to inform the work of the OMERACT Foot and Ankle Working Group.
Seminars in arthritis and rheumatismCaveolinopathy: Clinical, histological, and muscle imaging features and follow-up in a multicenter retrospective cohort.
European journal of neurologyDeveloping a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session.
Seminars in arthritis and rheumatismThe COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study.
Rheumatology internationalAssociation between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
RMD openBarriers and facilitators for physical activity in rheumatic and musculoskeletal disease: a European-based survey.
Clinical rheumatology2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice.
Annals of the rheumatic diseasesWhat Is in the Myopathy Literature?
Journal of clinical neuromuscular diseaseNursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review.
Clinical rheumatologyCoping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation.
Journal of patient-reported outcomesImmune-Mediated Rippling Muscle Disease Associated With Thymoma and Anti-MURC/Cavin-4 Autoantibodies.
Neurology(R) neuroimmunology & neuroinflammationImmune-mediated rippling muscle disease: not your usual muscle twitches and ache.
Neuromuscular disorders : NMDPrevalence of undiagnosed rheumatic and musculoskeletal diseases and its association with health-related quality of life and with physical function.
ARP rheumatologyDeveloping an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol.
TrialsNET-RMDs study: networks of fatigue and pain in rheumatic and musculoskeletal diseases - protocol for an international cross-sectional study.
BMJ openAmerican College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5.
Arthritis & rheumatology (Hoboken, N.J.)A Mixed-Methods Systematic Review on Syndemics in Rheumatology.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseasesFrequency and Pattern of Rheumatoid Arthritis in a Tertiary Hospital in Maiduguri, North-Eastern Nigeria.
West African journal of medicineObstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status.
Rheumatology (Oxford, England)2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work.
Annals of the rheumatic diseases[Rippling muscle disease with myasthenia gravis].
Rinsho shinkeigaku = Clinical neurologyIdentification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults.
JAMA neurologyEffects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
RMD openAmerican College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4.
Arthritis & rheumatology (Hoboken, N.J.)Exploring discordance between Health Literacy Questionnaire scores of people with RMDs and assessment by treating health professionals.
Rheumatology (Oxford, England)Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.
European journal of translational myology2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases.
Annals of the rheumatic diseasesEULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients' questions.
Annals of the rheumatic diseasesSafety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Annals of the rheumatic diseasesNeuromuscular hyperexcitability syndromes.
Current opinion in neurologyEULAR points to consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs).
Annals of the rheumatic diseasesSARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis.
Arthritis & rheumatology (Hoboken, N.J.)Rippling Muscle Disease with Irregular Toe Jerks and Anti-acetylcholine Receptor Antibodies: Remission after Extended Thymectomy.
Internal medicine (Tokyo, Japan)EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs.
Annals of the rheumatic diseasesImmunofluorescence-Based Analysis of Caveolin-3 in the Diagnostic Management of Neuromuscular Diseases.
Methods in molecular biology (Clifton, N.J.)Peripheral nerve hyperexcitability.
Handbook of clinical neurologyCoexistence of a CAV3 mutation and a DMD deletion in a family with complex muscular diseases.
Brain & developmentTeaching Video NeuroImages: Rippling muscle disease with caveolin myopathy.
NeurologySelf-diagnosis of a triple trouble.
Neuromuscular disorders : NMDCharacteristic findings of skeletal muscle MRI in caveolinopathies.
Neuromuscular disorders : NMDImmune-mediated rippling muscle disease in a patient with treated hypothyroidism.
Journal of the neurological sciencesCaveolin 3 deficiency myopathy associated with dyslipidemia: Treatment challenges and possible pathophysiological association.
Journal of clinical lipidologyImmune-mediated rippling muscle disease and myasthenia gravis.
Journal of neuroimmunologyCAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies.
Neuromuscular disorders : NMDMutation in the caveolin-3 gene causes asymmetrical distal myopathy.
Neuropathology : official journal of the Japanese Society of NeuropathologyCaveolinopathies in Greece.
The neurologistAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Doença de músculo rippling.
É de uma associação que acompanha esta doença? Fale com a gente →
Doença com base genética
Um médico geneticista pode ajudar no diagnóstico de Doença de músculo rippling e no aconselhamento genético da família.
Doenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Perguntas frequentes
O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu
É uma doença genética rara caracterizada por contrações dos músculos esqueléticos provocadas por estímulos mecânicos ou percussão. Ela está associada a alterações genéticas no gene CAV3, responsável pela proteína caveolina-3.
Referências
Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete
5 publicações do grafo RarasNet (PubMed) · 7 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Citar este verbete
Raras. (s.d.). Doença de músculo rippling. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/doenca-de-musculo-rippling
Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
Doença de músculo rippling
📋 Origem dos dados
Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.
- Doença rara (ontologia)
- fonte: Orphanet
- Identificador unificado
- fonte: MONDO
- Genética mendeliana
- fonte: OMIM
- Codificação WHO/SUS
- fonte: WHO ICD-10 / DATASUS
- CID-11 (futuro)
- fonte: WHO ICD-11
- NIH/GARD
- fonte: GARD (NIH)
- Indexação biomédica
- fonte: MeSH (NLM)
- Dado público estruturado
- fonte: Wikidata